特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
944820

注射ドラッグデリバリーの世界市場: 動向、予測、競合分析

Injectable Drug Delivery Market Report: Trends, Forecast and Competitive Analysis

出版日: | 発行: Lucintel - Semi-Custom Reports | ページ情報: 英文 | 納期: 約3~5週間

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円

【セミカスタムオーダー型の調査レポート】
当レポートは、目次内の調査項目について *追加/変更ご要望を反映させる事も可能です。
ご注文を承った時点からLucintel社データベースより最新のデータを抽出・分析・編集を行うため、納品には約3~5週間程度を要します。
* ご要望が無い場合は目次通りの内容構成にて作成となります。
* ご要望項目の分量によりましては追加費用が発生する場合がございます。

注射ドラッグデリバリーの世界市場: 動向、予測、競合分析
出版日: 2020年06月01日
発行: Lucintel - Semi-Custom Reports
ページ情報: 英文
納期: 約3~5週間
  • 全表示
  • 概要
  • 目次
概要

世界の注射ドラッグデリバリー市場は、2019年から2024年にかけて11%のCAGRで成長を続ける見通しです。市場拡大の主な原動力となるのは、慢性疾患の有病率の上昇、自己使用注射器の需要拡大、生物製剤市場の成長、技術の進歩、病院やクリニック、在宅医療での市場機会などの要因です。

当レポートは、世界の注射ドラッグデリバリー市場を調査したもので、これまでの動向と今後の予測、各地域市場の分析、競合情勢の分析、成長機会と戦略的な分析、主要企業のプロファイルなどの情報を提供しています。

第1章 エグゼクティブサマリー

第2章 市場の背景と分類

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の成長促進要因と課題

第3章 市場の動向と予測分析:2013年~2024年

  • マクロ経済の動向と予測
  • 世界市場の動向と予測
  • 製品タイプ別市場
    • 注射器
    • 製剤
  • 製剤パッケージ別市場
    • アンプル
    • バイアル
    • カートリッジ
    • びん
  • 用途別市場
    • 自己免疫疾患
    • ホルモン障害
    • 希少疾患
    • 腫瘍
    • その他
  • 使用パターン別市場
    • 治療的ケア
    • 予防接種
    • その他
  • 投与部位別市場
    • 皮膚
    • 循環器系/筋骨格系
    • 臓器
    • 中枢神経系
  • 流通チャネル別市場
    • 病院
    • 小売薬局
  • エンドユーザー別市場
    • 病院、診療所
    • 在宅ケア
    • その他

第4章 各地域市場の動向と予測分析

  • 地域別市場
  • 北米
    • エンドユーザー別市場
  • 欧州
    • エンドユーザー別市場
  • アジア太平洋
    • エンドユーザー別市場
  • その他の地域
    • エンドユーザー別市場

第5章 競合情勢の分析

  • 製品ポートフォリオ分析
  • 市場シェア分析
  • 業務統合
  • 事業展開している地域
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
  • 市場の新たなトレンド
  • 戦略的分析
    • 新製品の開発
    • 市場拡大
    • 合併、買収、合弁事業

第7章 主要企業のプロファイル

  • Becton, Dickinson And Company
  • Baxter International
  • Pfizer
  • Gerresheimer
  • Schott
  • Eli Lilly And Company
  • Terumo Corporation
目次

The future of the injectable drug delivery market looks promising with opportunities in the hospitals, clinics, and home care. The global injectable drug delivery market is expected to grow with a CAGR of 11% from 2019 to 2024. The major drivers for this market are rising prevalence of chronic diseases, increase in demand for self-injection devices, growth in the biologics market, and technological advancements.

A report of more than 150-pages is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of injectable drug delivery market report download the report brochure.

The study includes the injectable drug delivery market size and forecast for the global injectable drug delivery market through 2024, segmented by product type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and region as follows:

By Product Type [$M shipment analysis for 2013 - 2024]:

  • Devices
  • Formulations

By Formulation Packaging [$M shipment analysis for 2013 - 2024]:

  • Ampules
  • Vials
  • Cartridges
  • Bottles

By Therapeutic Application [$M shipment analysis for 2013 - 2024]:

  • Auto-immune diseases
  • Hormonal Disorders
  • Orphan Diseases
  • Oncology
  • Others

By Usage Pattern [$M shipment analysis for 2013 - 2024]:

  • Curative Care
  • Immunization
  • Other Usage Pattern

By Site of Administration [$M shipment analysis for 2013 - 2024]:

  • Skin
  • Circulatory/Musculoskeletal
  • Organs
  • Central Nervous System

By Distribution Channel [$M shipment analysis for 2013 - 2024]:

  • Hospitals
  • Retail Pharmacy Stores

By Facility of Use [$M shipment analysis for 2013 - 2024]:

  • Hospitals and Clinics
  • Home Care Settings
  • Other Facilities of Use

By Region [$M shipment analysis for 2013 - 2024]:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
  • Rest of the World (ROW)
    • Brazil

Some of the injectable drug delivery companies profiled in this report include Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer, Schott, Eli Lilly and Company, and Terumo are among the major manufacturers of injectable drug delivery market.

Some of the features of "Global Injectable Drug Delivery Market 2019-2024: Trends, Forecast, and Opportunity Analysis" include

  • Market size estimates:Global injectable drug delivery market size estimation in terms of value ($M) shipment.
  • Trend and forecast analysis:Market trend (2013-2018) and forecast (2019-2024) by segments and region.
  • Segmentation analysis:Global market size by product type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and region.
  • Regional analysis:Global injectable drug delivery market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth opportunities:Analysis on growth opportunities in different applications and regions for injectable drug delivery in the global injectable drug delivery market.
  • Strategic analysis:This includes M&A, new product development, and competitive landscape for injectable drug delivery in the global injectable drug delivery market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report addresses the following key questions:

  • Q.1. What are some of the most promising potential, high-growth opportunities for the global injectable drug delivery market by product type (devices and formulations), by formulation (ampules, vials, cartridges, and bottles),therapeutic application ( auto-immune diseases, hormonal disorders, orphan diseases, oncology and others), usage pattern (curative care, immunization and others), site of administration (skin, circulatory/ musculoskeletal, organs, and central nervous system), distribution channel (hospitals, and retail pharmacy stores), facility of use (hospitals & clinics, and home care settings), and region (North America, Europe, Asia-Pacific, and Rest of the World (ROW))?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which regions will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the injectable drug delivery market?
  • Q.5. What are the business risks and threats to the injectable drug delivery market?
  • Q.6. What are emerging trends in this injectable drug delivery market and the reasons behind them?
  • Q.7. What are some changing demands of customers in the injectable drug delivery market?
  • Q.8. What are the new developments in the injectable drug delivery market? Which companies are leading these developments?
  • Q.9. Who are the major players in this injectable drug delivery market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10. What are some of the competitive products and processes in this injectable drug delivery area and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11. What M & A activities have taken place in the last 5 years in this injectable drug delivery market?

1. Executive Summary

2. Market Background and Classifications

  • 2.1. Introduction, Background, and Classifications
  • 2.2. Supply Chain
  • 2.3. Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2013 to 2024

  • 3.1: Macroeconomic Trends and Forecast
  • 3.2: Global Injectable Drug Delivery Market: Trends and Forecast
  • 3.3: Global Injectable Drug Delivery Market by Product Type
    • 3.3.1: Devices
    • 3.3.2: Formulations
  • 3.4: Global Injectable Drug Delivery Market by Formulation Packaging
    • 3.4.1: Ampules
    • 3.4.2: Vials
    • 3.4.3: Cartridges
    • 3.4.4: Bottles
  • 3.5: Global Injectable Drug Delivery Market by Application
    • 3.5.1: Auto-immune diseases
    • 3.5.2: Hormonal Disorders
    • 3.5.3: Orphan Diseases
    • 3.5.4: Oncology
    • 3.5.5: Others
  • 3.6: Global Injectable Drug Delivery Market by Usage Pattern
    • 3.6.1: Curative Care
    • 3.6.2: Immunization
    • 3.6.3: Other Usage Pattern
  • 3.7: Global Injectable Drug Delivery Market by Site of Administration
    • 3.7.1: Skin
    • 3.7.2: Circulatory/Musculoskeletal
    • 3.7.3: Organs
    • 3.7.4: Central Nervous System
  • 3.8: Global Injectable Drug Delivery Market by Distribution Channel
    • 3.8.1: Hospitals
    • 3.8.2: Retail Pharmacy Stores
  • 3.9: Global Injectable Drug Delivery Market by End Use Industry
    • 3.9.1: Hospitals & Clinics
    • 3.9.2: Home Care Settings
    • 3.9.3: Other

4. Market Trends and Forecast Analysis by Region

  • 4.1: Global Injectable Drug Delivery Market by Region
  • 4.2: North American Injectable Drug Delivery Market
    • 4.2.1: Market by End Use Industry: Hospitals & Clinics, Home Care Settings, and Other Facilities Of Use
  • 4.3: European Injectable Drug Delivery Market
    • 4.3.1: Market by End Use Industry: Hospitals & Clinics, Home Care Settings, and Other Facilities of Use
  • 4.4: APAC Injectable Drug Delivery Market
    • 4.4.1: Market by End Use Industry: Hospitals & Clinics, Home Care Settings, and other Facilities of Use
  • 4.5: ROW Injectable Drug Delivery Market
    • 4.5.1: Market by End Use Industry: Hospitals & Clinics, Home Care Settings, and other Facilities Of Use

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Market Share Analysis
  • 5.3: Operational Integration
  • 5.4: Geographical Reach
  • 5.5: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for Global Injectable Drug Delivery Market by End Use Industry
    • 6.1.2: Growth Opportunities for Global Injectable Drug Delivery Market by Product type
    • 6.1.3: Growth Opportunities for Global Market by Formulation Packaging
    • 6.1.4: Growth Opportunities for Global Market by Application
    • 6.1.5: Growth Opportunities for Global Market by Usage Pattern
    • 6.1.6: Growth Opportunities for Global Market by Site of Administration
    • 6.1.7: Growth Opportunities for Global Market by Distribution Channel
    • 6.1.8: Growth Opportunities for Global Injectable Drug Delivery Market by Region
  • 6.2: Emerging Trends in Global Injectable Drug Delivery Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of Global Injectable Drug Delivery Market
    • 6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Market

7. Company Profiles of Leading Players

  • 7.1: Becton, Dickinson And Company
  • 7.2: Baxter International
  • 7.3: Pfizer
  • 7.4: Gerresheimer
  • 7.5: Schott
  • 7.6: Eli Lilly And Company
  • 7.7: Terumo Corporation
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.